LCTX Competitors & Alternatives
Compare Lineage Cell Therapeutics Inc with similar stocks in the same industry
Biotechnology
LCTX
Main Stock$0.77
-5.87%
Tradestie Score
56
Market Cap
$385.92M
Revenue Growth
-61.0%
Analyst Upside
+612.5%
Supply-Chain & Ecosystem Map (Customers, Suppliers & Direct Competitors)
Bottleneck Score: 1/10
Drug Discovery Biotech
Cell Therapy
Top Competitors
215 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
VTYX
Ventyx Biosciences, Inc. Common Stock
|
$14.00
+0.14%
|
$256.71M | - | 51 | Compare |
|
CYPH
CYPH
|
$1.41
-18.02%
|
$256.35M | 0.8 | 49 | Compare |
|
SLN
Silence Therapeutics Plc American Depository Share
|
$19.81
|
$240.89M | - | 46 | Compare |
|
OABI
OmniAb, Inc. Common Stock
|
$4.66
-7.36%
|
$231.77M | - | 46 | Compare |
|
SGMT
Sagimet Biosciences Inc. Series A Common Stock
|
$9.08
-5.61%
|
$227.00M | - | 45 | Compare |
|
SLS
SELLAS Life Sciences Group, Inc. Common Stock
|
$13.66
-8.08%
|
$211.22M | - | 36 | Compare |
|
ACRS
Aclaris Therapeutics, Inc.
|
$3.44
-1.71%
|
$202.58M | - | 42 | Compare |
|
CBIO
Crescent Biopharma, Inc. Common Stock
|
$13.00
+0.70%
|
$199.71M | - | 49 | Compare |
|
FBRX
Forte Biosciences, Inc. Common Stock
|
$76.99
+0.03%
|
$180.53M | - | 54 | Compare |
|
ACHV
Achieve Life Sciences, Inc.
|
$6.78
+0.89%
|
$158.43M | - | 56 | Compare |
More LCTX Analysis
Data updated: Nov 20, 2026 | Industry: Biotechnology (SIC 2836)
215 stocks in this industry